2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,738,326 | -59.7% | 2,994,471 | +4.0% | 0.00% | -66.7% |
| Q2 2023 | $29,144,811 | +3.2% | 2,879,922 | +4.0% | 0.01% | 0.0% |
| Q1 2023 | $28,248,308 | -1.1% | 2,769,442 | -9.1% | 0.01% | 0.0% |
| Q4 2022 | $28,555,882 | -38.9% | 3,047,586 | -5.1% | 0.01% | -40.0% |
| Q3 2022 | $46,735,000 | +21.9% | 3,212,011 | +10.6% | 0.01% | +25.0% |
| Q2 2022 | $38,351,000 | -10.5% | 2,905,367 | +15.7% | 0.01% | +14.3% |
| Q1 2022 | $42,854,000 | -20.0% | 2,511,955 | +20.2% | 0.01% | -22.2% |
| Q4 2021 | $53,573,000 | – | 2,090,255 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 5,953,825 | $23,338,994 | 3.82% |
| Newtyn Management, LLC | 3,076,490 | $12,059,841 | 2.98% |
| DAFNA Capital Management LLC | 1,447,465 | $5,674,063 | 1.76% |
| CHI Advisors LLC | 1,002,007 | $3,927,867 | 1.56% |
| AlphaCentric Advisors LLC | 657,500 | $2,577,400 | 1.46% |
| Casdin Capital, LLC | 2,023,913 | $7,933,739 | 0.88% |
| Madison Avenue Partners, LP | 1,494,125 | $5,856,970 | 0.83% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $5,522,892 | 0.62% |
| Eversept Partners, LP | 1,453,378 | $5,697,242 | 0.48% |
| Engine Capital Management, LP | 341,870 | $1,340,130 | 0.30% |